ADVFN Logo ADVFN

We could not find any results for:
Make sure your spelling is correct or try broadening your search.

Trending Now

Toplists

It looks like you aren't logged in.
Click the button below to log in and view your recent history.

Hot Features

Registration Strip Icon for discussion Register to chat with like-minded investors on our interactive forums.

BQE Bioquell

597.00
0.00 (0.00%)
Last Updated: 01:00:00
Delayed by 15 minutes
Share Name Share Symbol Market Type Share ISIN Share Description
Bioquell LSE:BQE London Ordinary Share GB0004992003 ORD 10P
  Price Change % Change Share Price Bid Price Offer Price High Price Low Price Open Price Shares Traded Last Trade
  0.00 0.00% 597.00 0.00 01:00:00
Industry Sector Turnover Profit EPS - Basic PE Ratio Market Cap
0 0 N/A 0

Bioquell PLC Director/PDMR Shareholding, Exercise of Options (6172A)

27/03/2017 11:15am

UK Regulatory


Bioquell (LSE:BQE)
Historical Stock Chart


From Apr 2019 to Apr 2024

Click Here for more Bioquell Charts.

TIDMBQE

RNS Number : 6172A

Bioquell PLC

27 March 2017

To: Companies Announcement Office

FOR IMMEDIATE RELEASE

27 March 2017

Bioquell PLC

PDMR Dealing, exercise of share options and issue of new ordinary shares

Bioquell PLC announces that it has issued 36,511 ordinary shares of 10p each following the exercise of options under the Company's share option and SAYE schemes. The 36,511 new Ordinary Shares comprise 4,130 Ordinary Shares allotted on 22 March 2017 and 32,381 Ordinary Shares allotted on 24 March 2017. The option exercises have been satisfied by the Company's block listing arrangements.

The exercise of options on 24 March 2017 comprised the exercise by Michael Roller, PDMR, of options over 32,381 Ordinary Shares.

The issued share capital of the Company is now comprised of 22,981,291 Ordinary Shares of 10p each. As 632,000 of these Ordinary Shares are held as treasury shares, the total number of voting rights in the company is 22,349,291. This figure may be used by shareholders as the denominator for the calculations by which they will determine if they are required to notify their interest in, or a change to their interest in, the Company under the FCA's Disclosure Guidance and Transparency Rules.

The notification below, made in accordance with the requirements of the EU Market Abuse Regulation, provides further detail on the PDMR transaction:

Notification and public disclosure of transactions by persons discharging managerial responsibilities and persons closely associated with them

 
1   Details of the person discharging managerial responsibilities / person closely associated 
 
a)  Name                                            Michael Roller 
2   Reason for the notification - Exercise of options over Ordinary Shares 
a)  Position/status                                 Finance Director 
b)  Initial notification /Amendment                 Initial notification 
3   Details of the issuer, emission allowance market participant, auction platform, auctioneer 
     or auction monitor 
a)  Name                                            Bioquell Plc 
b)  LEI                                             2138 005 BQVKIZE 84122 
a)  Description of the financial instrument,        Options over Ordinary Shares of GBP0.10 
     type of instrument 
     Identification code                             GB0004992003 
b)  Nature of the transaction                       Exercise of options 
c)  Price(s) and volume(s)                          Price(s)  Volume(s) 
                                                     92.5p     32,381 
d)  Aggregated information 
     - Aggregated volume                             N/A - single transaction 
     - Price 
e)  Date of the transaction                         24 March 2017 
f)  Place of the transaction                        n/a 
d)  Aggregated information 
     - Aggregated volume                             N/A - single transaction 
     - Price 
e)  Date of the transaction                         24 March 2017 
f)  Place of the transaction                        Off market 
 

Ends

Enquiries:

Georgina Pope

Bioquell PLC

01264 835 900

This information is provided by RNS

The company news service from the London Stock Exchange

END

DSHEAEDXAFLXEFF

(END) Dow Jones Newswires

March 27, 2017 06:15 ET (10:15 GMT)

1 Year Bioquell Chart

1 Year Bioquell Chart

1 Month Bioquell Chart

1 Month Bioquell Chart

Your Recent History

Delayed Upgrade Clock